Examine the data and tweets to deduce if the closing price of $bmy will boost or lower at 2017-06-27. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-13,0.0,0.2,-0.5,-0.3,-0.3,-1.2,-1.2,-0.9,-0.7,-0.2,0.2
2017-06-14,-0.5,0.5,-0.7,0.6,0.6,-1.1,-1.7,-1.5,-1.3,-0.9,-0.5
2017-06-15,0.4,0.8,-0.5,-0.4,-0.4,-0.1,-1.3,-1.0,-0.9,-0.5,-0.1
2017-06-16,0.1,0.3,-1.6,0.3,0.3,-0.2,-1.8,-1.3,-1.1,-0.9,-0.5
2017-06-19,-1.4,0.3,-1.6,1.4,1.4,-1.2,-2.6,-2.5,-2.4,-2.2,-1.9
2017-06-20,-0.7,1.3,-1.0,0.8,0.8,-1.5,-2.6,-3.1,-3.0,-3.0,-2.6
2017-06-21,-0.6,0.9,-0.8,0.7,0.7,-1.7,-2.7,-3.5,-3.6,-3.5,-3.3
2017-06-22,-1.8,1.0,-2.1,2.2,2.2,-2.8,-4.1,-5.3,-5.4,-5.5,-5.3
2017-06-23,1.1,1.3,-0.7,-1.2,-1.2,-0.8,-2.4,-4.0,-4.0,-4.1,-4.0
2017-06-26,-0.4,0.6,-1.0,0.5,0.5,-0.7,-2.4,-3.9,-4.2,-4.4,-4.4

2017-06-13: dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $bmy $vz  #stockmarket #stocks #trading #dowjones|dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $bmy $vz  #sto
2017-06-14: salphatrending: bristol-myers squibb's (bmy) management presents at goldman sachs 38th annual global health...  $bmy|bristol-myers squibb's (bmy) management presents at goldman sachs 38th annual globa
2017-06-15: ltm ebitda multiple of gilead sciences, inc. $gild is currently below all peers: $abbv $bmy $lly $mrk $pfe¡­ |$bmy then bear pattern is not confirmed. a new bear pattern is detected.|AT_USER seeing a 
2017-06-16: 6 reasons why prescription drug prices are extremely expensive AT_USER #stocks $pfe, $bmrn, $bmy, $lly, $abbv |$myo regardless they going to get bought out hearing they have a very impressive board. m
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |if your a #dad #mom #child you deserve better tratments for #cancer exciting times ahead $nwbo $kite $bmy 
2017-06-18: final read out coming soon $nwbo #dcvax-l just the beginning. $kite and others like $juno $bmy $agio $fgen doing am¡­ 
2017-06-19: rt AT_USER targeting the pd-1/pd-l1 immune checkpoint inegfr-mutated oralk-translocated nsclc $azn $mrk $bmy $rog $nvs |#bristolmyerssquibb bristol-myers squibb is poised for a breakout. read more:  $
2017-06-20: #bristolmyerssquibb bristolmyers squibb announces the pricing terms of its cash tender offer... read more:  $bmy|#bristolmyerssquibb bristolmyers squibb announces the pricing terms of its cash tender 
2017-06-21: biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn $amgn $biib $vrtx |biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn
2017-06-22: $ksu $bmy $spg $wb $acn $jack $pvh day trader setups traders live chatroom membership  #daytrading #tradingchatrooms|need help finding momentum stocks?   $htgm $jah $clr $dis $mo $bmy $pot $apa $cnq $
2017-06-23: get the latest ratings for $szmk $bned $ades $pwr $bmy in your inbox with marketbeat daily |AT_USER AT_USER analysis by #australia #biotechnology $nwbo collaborated with $bmy $mrk analyst¡­ |rt AT_USE
2017-06-24: rt AT_USER $bmy #bristol-myers squibb co. four-year follow-up with empliciti (elotuzumab) plus lenalidomide/dexametha... |$bmy #bristol-myers squibb co. four-year follow-up with empliciti (elotuzumab)
2017-06-25: analysts set bristol-myers squibb company $bmy target price at $61.62 |rt AT_USER $vdrm $frzt $chro $icnb $kerx $pfe $mrk $adxs $bmy $bac $c $gs $jpm $amd $dcth $csco $qqq $eled $nvax $mu $jd $ttd $an
2017-06-26: $0.74 earnings per share expected for bristol-myers squibb company $bmy this quarter |$0.74 earnings per share expected for bristol-myers squibb company $bmy this quarter |rt AT_USER $vdrm $frzt $chro
Answer:
Examine the data and tweets to deduce if the closing price of $bmy will boost or lower at 2017-06-27. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-13,0.0,0.2,-0.5,-0.3,-0.3,-1.2,-1.2,-0.9,-0.7,-0.2,0.2
2017-06-14,-0.5,0.5,-0.7,0.6,0.6,-1.1,-1.7,-1.5,-1.3,-0.9,-0.5
2017-06-15,0.4,0.8,-0.5,-0.4,-0.4,-0.1,-1.3,-1.0,-0.9,-0.5,-0.1
2017-06-16,0.1,0.3,-1.6,0.3,0.3,-0.2,-1.8,-1.3,-1.1,-0.9,-0.5
2017-06-19,-1.4,0.3,-1.6,1.4,1.4,-1.2,-2.6,-2.5,-2.4,-2.2,-1.9
2017-06-20,-0.7,1.3,-1.0,0.8,0.8,-1.5,-2.6,-3.1,-3.0,-3.0,-2.6
2017-06-21,-0.6,0.9,-0.8,0.7,0.7,-1.7,-2.7,-3.5,-3.6,-3.5,-3.3
2017-06-22,-1.8,1.0,-2.1,2.2,2.2,-2.8,-4.1,-5.3,-5.4,-5.5,-5.3
2017-06-23,1.1,1.3,-0.7,-1.2,-1.2,-0.8,-2.4,-4.0,-4.0,-4.1,-4.0
2017-06-26,-0.4,0.6,-1.0,0.5,0.5,-0.7,-2.4,-3.9,-4.2,-4.4,-4.4

2017-06-13: dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $bmy $vz  #stockmarket #stocks #trading #dowjones|dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $bmy $vz  #sto
2017-06-14: salphatrending: bristol-myers squibb's (bmy) management presents at goldman sachs 38th annual global health...  $bmy|bristol-myers squibb's (bmy) management presents at goldman sachs 38th annual globa
2017-06-15: ltm ebitda multiple of gilead sciences, inc. $gild is currently below all peers: $abbv $bmy $lly $mrk $pfe¡­ |$bmy then bear pattern is not confirmed. a new bear pattern is detected.|AT_USER seeing a 
2017-06-16: 6 reasons why prescription drug prices are extremely expensive AT_USER #stocks $pfe, $bmrn, $bmy, $lly, $abbv |$myo regardless they going to get bought out hearing they have a very impressive board. m
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |if your a #dad #mom #child you deserve better tratments for #cancer exciting times ahead $nwbo $kite $bmy 
2017-06-18: final read out coming soon $nwbo #dcvax-l just the beginning. $kite and others like $juno $bmy $agio $fgen doing am¡­ 
2017-06-19: rt AT_USER targeting the pd-1/pd-l1 immune checkpoint inegfr-mutated oralk-translocated nsclc $azn $mrk $bmy $rog $nvs |#bristolmyerssquibb bristol-myers squibb is poised for a breakout. read more:  $
2017-06-20: #bristolmyerssquibb bristolmyers squibb announces the pricing terms of its cash tender offer... read more:  $bmy|#bristolmyerssquibb bristolmyers squibb announces the pricing terms of its cash tender 
2017-06-21: biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn $amgn $biib $vrtx |biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn
2017-06-22: $ksu $bmy $spg $wb $acn $jack $pvh day trader setups traders live chatroom membership  #daytrading #tradingchatrooms|need help finding momentum stocks?   $htgm $jah $clr $dis $mo $bmy $pot $apa $cnq $
2017-06-23: get the latest ratings for $szmk $bned $ades $pwr $bmy in your inbox with marketbeat daily |AT_USER AT_USER analysis by #australia #biotechnology $nwbo collaborated with $bmy $mrk analyst¡­ |rt AT_USE
2017-06-24: rt AT_USER $bmy #bristol-myers squibb co. four-year follow-up with empliciti (elotuzumab) plus lenalidomide/dexametha... |$bmy #bristol-myers squibb co. four-year follow-up with empliciti (elotuzumab)
2017-06-25: analysts set bristol-myers squibb company $bmy target price at $61.62 |rt AT_USER $vdrm $frzt $chro $icnb $kerx $pfe $mrk $adxs $bmy $bac $c $gs $jpm $amd $dcth $csco $qqq $eled $nvax $mu $jd $ttd $an
2017-06-26: $0.74 earnings per share expected for bristol-myers squibb company $bmy this quarter |$0.74 earnings per share expected for bristol-myers squibb company $bmy this quarter |rt AT_USER $vdrm $frzt $chro
Answer:+Fall